[LS-33] Luncheon Seminar 33　The Importance of Evidence-Based Anti-CD20 Therapies

[LS-33-1] Early High Efficacy Therapy and Shared Decision Making

Yuji Tomizawa (Juntendo University Faculty of Medicine, Japan)